{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:13:22Z","timestamp":1790176402591,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Young National Natural Science Fund of China","award":["81500101"],"award-info":[{"award-number":["81500101"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["81570111"],"award-info":[{"award-number":["81570111"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tianjin Applied Basic Research Project Fund","award":["15JCYBJC24300"],"award-info":[{"award-number":["15JCYBJC24300"]}]},{"name":"Tianjin Medical University General Hospital Young Incubation fund","award":["ZYYFY2014026"],"award-info":[{"award-number":["ZYYFY2014026"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.leukres.2016.11.003","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T00:30:48Z","timestamp":1478133048000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Increased TIM3+CD8+T cells in Myelodysplastic Syndrome patients displayed less perforin and granzyme B secretion and higher CD95 expression"],"prefix":"10.1016","volume":"51","author":[{"given":"Jinglian","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.leukres.2016.11.003_bib0005","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.leukres.2014.03.018","article-title":"Elevated TIM3+ hematopoietic stem cells in untreated myelodysplastic syndrome displayed aberrant differentiation, overproliferation and decreased apoptosis","volume":"38","author":"Tao1","year":"2014","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.leukres.2016.11.003_bib0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12185-014-1590-2","article-title":"Increased CD34+CD38-CD123+ cells in myelodysplastic syndrome displaying malignant features similar to those in AML","volume":"100","author":"Tao1","year":"2014","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2016.11.003_bib0015","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.leukres.2013.04.008","article-title":"CD47 is expressed abnormally on hematopoietic cells in myelodysplastic syndrome","volume":"37","author":"Jiang","year":"2013","journal-title":"Leuk. Res."},{"issue":"June (6)","key":"10.1016\/j.leukres.2016.11.003_bib0020","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1158\/2326-6066.CIR-14-0201","article-title":"French JD. PD-1\u2009+\u2009Tim-3+ CD8+ t lymphocytes display varied degrees of functional exhaustion in patients with regionally metastatic differentiated thyroid cancer","volume":"3","author":"Severson","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"August (8)","key":"10.1016\/j.leukres.2016.11.003_bib0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.it.2011.05.003","article-title":"Emerging Tim-3 functions in anti-microbial and tumor immunity","volume":"32","author":"Sakuishi","year":"2011","journal-title":"Trends Immunol."},{"issue":"5853","key":"10.1016\/j.leukres.2016.11.003_bib0030","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.1148536","article-title":"Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells","volume":"318","author":"Anderson","year":"2007","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.leukres.2016.11.003_bib0035","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1158\/0008-5472.CAN-11-1487","article-title":"Prospects for TIM3-targeted antitumor immunotherapy","volume":"71","author":"Ngiow","year":"2011","journal-title":"Cancer Res."},{"issue":"July (13)","key":"10.1016\/j.leukres.2016.11.003_bib0040","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3760\/cma.j.issn.0366-6999.20121794","article-title":"Increased circulating of myeloid-derived suppressor cells in myelodysplastic syndrome","volume":"126","author":"Jiang","year":"2013","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"177","key":"10.1016\/j.leukres.2016.11.003_bib0045","doi-asserted-by":"crossref","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"17","key":"10.1016\/j.leukres.2016.11.003_bib0050","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2011-10-387969","article-title":"Maloney DG. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results","volume":"119","author":"Till","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2016.11.003_bib0055","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.leukres.2016.11.003_bib0060","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/QAD.0000000000000589","article-title":"Up-regulation of Tim-3 on T cells during acute simian immunodeficiency virus infection and on antigen specific responders","volume":"29","author":"Amancha","year":"2015","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.leukres.2016.11.003_bib0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2567.2010.03255.x","article-title":"T-cell exhaustion: characteristics, causes and conversion","volume":"129","author":"Yi","year":"2010","journal-title":"Immunology"},{"issue":"February","key":"10.1016\/j.leukres.2016.11.003_bib0070","first-page":"19","article-title":"French JD. PD-1\u2009+\u2009Tim-3 + CD8+ t lymphocytes display varied degrees of functional exhaustion in patients with regionally metastatic differentiated thyroid cancer","author":"Severson","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"February (7)","key":"10.1016\/j.leukres.2016.11.003_bib0075","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1038\/ncomms10501","article-title":"Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints","volume":"17","author":"Koyama","year":"2016","journal-title":"Nat. Commun."},{"issue":"December (12)","key":"10.1016\/j.leukres.2016.11.003_bib0080","first-page":"858","article-title":"Programmed death 1 immune checkpoint inhibitors","volume":"13","author":"Trivedi","year":"2015","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"October (10)","key":"10.1016\/j.leukres.2016.11.003_bib0085","first-page":"676","article-title":"PD-1\/PD-L1 immune checkpoint blockade in non-small cell lung cancer","volume":"13","author":"Bagley","year":"2015","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"December (4)","key":"10.1016\/j.leukres.2016.11.003_bib0090","first-page":"455","article-title":"Fuertes Marraco Inhibitory receptor expression depends more dominantly on differentiation and activation than exhaustion of human CD8 T cells","volume":"19","author":"Legat","year":"2013","journal-title":"Front. Immunol."},{"issue":"April (17)","key":"10.1016\/j.leukres.2016.11.003_bib0095","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood-2010-10-310425","article-title":"Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia","volume":"117","author":"Zhou","year":"2011","journal-title":"Blood"},{"issue":"April (4)","key":"10.1016\/j.leukres.2016.11.003_bib0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/cdd.2015.3","article-title":"The role of CD95 and CD95 ligand in cancer","volume":"22","author":"Peter","year":"2015","journal-title":"Cell Death Differ."},{"issue":"May (7297)","key":"10.1016\/j.leukres.2016.11.003_bib0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature09075","article-title":"Peter ME.CD95 promotes tumour growth","volume":"465","author":"Chen","year":"2010","journal-title":"Nature"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616302430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616302430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T09:41:24Z","timestamp":1718876484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212616302430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":21,"alternative-id":["S0145212616302430"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2016.11.003","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased TIM3+CD8+T cells in Myelodysplastic Syndrome patients displayed less perforin and granzyme B secretion and higher CD95 expression","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2016.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}